141 related articles for article (PubMed ID: 18301733)
21. Immunomodulation mediated by a herbal syrup containing a standardized Echinacea root extract: a pilot study in healthy human subjects on cytokine gene expression.
Dapas B; Dall'Acqua S; Bulla R; Agostinis C; Perissutti B; Invernizzi S; Grassi G; Voinovich D
Phytomedicine; 2014 Sep; 21(11):1406-10. PubMed ID: 24877712
[TBL] [Abstract][Full Text] [Related]
22. Diacetylenic isobutylamides of Echinacea: synthesis and natural distribution.
Wu L; Bae J; Kraus G; Wurtele ES
Phytochemistry; 2004 Sep; 65(17):2477-84. PubMed ID: 15381412
[TBL] [Abstract][Full Text] [Related]
23.
Cadiz MP; Schara MR; Kemp BH; Gibbons Johnson RM
J Med Food; 2019 Nov; 22(11):1146-1150. PubMed ID: 31274384
[No Abstract] [Full Text] [Related]
24. Effects of Echinacea extracts on macrophage antiviral activities.
Senchina DS; Martin AE; Buss JE; Kohut ML
Phytother Res; 2010 Jun; 24(6):810-6. PubMed ID: 20041425
[TBL] [Abstract][Full Text] [Related]
25. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
Chicca A; Raduner S; Pellati F; Strompen T; Altmann KH; Schoop R; Gertsch J
Int Immunopharmacol; 2009 Jul; 9(7-8):850-8. PubMed ID: 19303464
[TBL] [Abstract][Full Text] [Related]
26. Identifying commercially relevant Echinacea species by AFLP molecular markers.
Russi L; Moretti C; Raggi L; Albertini E; Falistocco E
Genome; 2009 Nov; 52(11):912-8. PubMed ID: 19935915
[TBL] [Abstract][Full Text] [Related]
27. [Echinacea drugs--effects and active ingredients].
Bauer R
Z Arztl Fortbild (Jena); 1996 Apr; 90(2):111-5. PubMed ID: 8686333
[TBL] [Abstract][Full Text] [Related]
28. Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells.
LaLone CA; Hammer KD; Wu L; Bae J; Leyva N; Liu Y; Solco AK; Kraus GA; Murphy PA; Wurtele ES; Kim OK; Seo KI; Widrlechner MP; Birt DF
J Agric Food Chem; 2007 Sep; 55(18):7314-22. PubMed ID: 17696440
[TBL] [Abstract][Full Text] [Related]
29. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.
Sasagawa M; Cech NB; Gray DE; Elmer GW; Wenner CA
Int Immunopharmacol; 2006 Jul; 6(7):1214-21. PubMed ID: 16714226
[TBL] [Abstract][Full Text] [Related]
30. Sequence characterized amplified region (SCAR) analysis on DNA from the three medicinal Echinacea species.
Adinolfi B; Chicca A; Martinotti E; Breschi MC; Nieri P
Fitoterapia; 2007 Jan; 78(1):43-5. PubMed ID: 17067760
[TBL] [Abstract][Full Text] [Related]
31. Effects of oral administration of Echinacea purpurea (American herb) on incidence of spontaneous leukemia caused by recombinant leukemia viruses in AKR/J mice.
Hayashi I; Ohotsuki M; Suzuki I; Watanabe T
Nihon Rinsho Meneki Gakkai Kaishi; 2001 Feb; 24(1):10-20. PubMed ID: 11280896
[TBL] [Abstract][Full Text] [Related]
32. Proliferative activity of a blend of Echinacea angustifolia and Echinacea purpurea root extracts in human vein epithelial, HeLa, and QBC-939 cell lines, but not in Beas-2b cell lines.
Cichello SA; Yao Q; He XQ
J Tradit Complement Med; 2016 Apr; 6(2):193-7. PubMed ID: 27114944
[TBL] [Abstract][Full Text] [Related]
33. Echinacea-induced cytokine production by human macrophages.
Burger RA; Torres AR; Warren RP; Caldwell VD; Hughes BG
Int J Immunopharmacol; 1997 Jul; 19(7):371-9. PubMed ID: 9568541
[TBL] [Abstract][Full Text] [Related]
34. Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation.
Zhai Z; Solco A; Wu L; Wurtele ES; Kohut ML; Murphy PA; Cunnick JE
J Ethnopharmacol; 2009 Feb; 122(1):76-85. PubMed ID: 19111603
[TBL] [Abstract][Full Text] [Related]
35. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial.
Melchart D; Walther E; Linde K; Brandmaier R; Lersch C
Arch Fam Med; 1998; 7(6):541-5. PubMed ID: 9821828
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory and cicatrizing activity of Echinacea pallida Nutt. root extract.
Speroni E; Govoni P; Guizzardi S; Renzulli C; Guerra MC
J Ethnopharmacol; 2002 Feb; 79(2):265-72. PubMed ID: 11801391
[TBL] [Abstract][Full Text] [Related]
37. Use of quantitative flow cytometry to measure ex vivo immunostimulant activity of echinacea: the case for polysaccharides.
Pillai S; Pillai C; Mitscher LA; Cooper R
J Altern Complement Med; 2007; 13(6):625-34. PubMed ID: 17718645
[TBL] [Abstract][Full Text] [Related]
38. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.
Gulledge TV; Collette NM; Mackey E; Johnstone SE; Moazami Y; Todd DA; Moeser AJ; Pierce JG; Cech NB; Laster SM
J Ethnopharmacol; 2018 Feb; 212():166-174. PubMed ID: 29042288
[TBL] [Abstract][Full Text] [Related]
39. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system.
Woelkart K; Marth E; Suter A; Schoop R; Raggam RB; Koidl C; Kleinhappl B; Bauer R
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):401-8. PubMed ID: 16995328
[TBL] [Abstract][Full Text] [Related]
40. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats.
Goel V; Chang C; Slama JV; Barton R; Bauer R; Gahler R; Basu TK
Int Immunopharmacol; 2002 Feb; 2(2-3):381-7. PubMed ID: 11811940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
